These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7635947)

  • 21. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice.
    van Ree JH; van den Broek WJ; Dahlmans VE; Groot PH; Vidgeon-Hart M; Frants RR; Wieringa B; Havekes LM; Hofker MH
    Atherosclerosis; 1994 Nov; 111(1):25-37. PubMed ID: 7840811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice.
    Yu H; Zhang W; Yancey PG; Koury MJ; Zhang Y; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):150-6. PubMed ID: 16269665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ; van den Maagdenberg AM; Gijbels MJ; van der Boom H; HogenEsch H; Frants RR; Hofker MH; Havekes LM
    J Clin Invest; 1994 Apr; 93(4):1403-10. PubMed ID: 8163645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in plasma apo B, apo E, apo A-I, and apo A-IV concentrations in dogs consuming different atherogenic diets.
    Melchior GW; Dory L; Roheim PS
    Atherosclerosis; 1984 Jul; 52(1):47-57. PubMed ID: 6432002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of PLTP is atherogenic in apolipoprotein E deficient mice.
    van Haperen R; van Gent T; van Tol A; de Crom R
    Atherosclerosis; 2013 Mar; 227(1):37-42. PubMed ID: 23313246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I(Milano)-phospholipid complex.
    Kaul S; Coin B; Hedayiti A; Yano J; Cercek B; Chyu KY; Shah PK
    J Am Coll Cardiol; 2004 Sep; 44(6):1311-9. PubMed ID: 15364338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased ICAM-1 and PECAM-1 transcription levels in the heart of Apo-E deficient mice in comparison to wild type (C57BL6).
    Zibara K; Chettab K; McGregor B; Poston R; McGregor J
    Thromb Haemost; 2001 May; 85(5):908-14. PubMed ID: 11372687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation.
    Marathe S; Choi Y; Leventhal AR; Tabas I
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2607-13. PubMed ID: 11116060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
    Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
    Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic background determines the extent of atherosclerosis in ApoE-deficient mice.
    Dansky HM; Charlton SA; Sikes JL; Heath SC; Simantov R; Levin LF; Shu P; Moore KJ; Breslow JL; Smith JD
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1960-8. PubMed ID: 10446078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
    Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
    Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actions of ferulic acid and vitamin E on prevention of hypercholesterolemia and atherogenic lesion formation in apolipoprotein E-deficient mice.
    Kwon EY; Cho YY; Do GM; Kim HJ; Jeon SM; Park YB; Lee MK; Min TS; Choi MS
    J Med Food; 2009 Oct; 12(5):996-1003. PubMed ID: 19857062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apo E structure determines VLDL clearance and atherosclerosis risk in mice.
    Knouff C; Hinsdale ME; Mezdour H; Altenburg MK; Watanabe M; Quarfordt SH; Sullivan PM; Maeda N
    J Clin Invest; 1999 Jun; 103(11):1579-86. PubMed ID: 10359567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
    Pászty C; Maeda N; Verstuyft J; Rubin EM
    J Clin Invest; 1994 Aug; 94(2):899-903. PubMed ID: 8040345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of atherosclerotic lesion development in mice by taurine.
    Murakami S; Kondo Y; Tomisawa K; Nagate T
    Drugs Exp Clin Res; 1999; 25(5):227-34. PubMed ID: 10568211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.
    Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y
    J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors.
    Kashyap VS; Santamarina-Fojo S; Brown DR; Parrott CL; Applebaum-Bowden D; Meyn S; Talley G; Paigen B; Maeda N; Brewer HB
    J Clin Invest; 1995 Sep; 96(3):1612-20. PubMed ID: 7657831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
    Zhou X; Paulsson G; Stemme S; Hansson GK
    J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.
    Shimano H; Ohsuga J; Shimada M; Namba Y; Gotoda T; Harada K; Katsuki M; Yazaki Y; Yamada N
    J Clin Invest; 1995 Feb; 95(2):469-76. PubMed ID: 7860728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.